{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:01:27Z","timestamp":1786996887255,"version":"build-2736575974"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sleep Medicine"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.sleep.2026.109006","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T12:53:16Z","timestamp":1778244796000},"page":"109006","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Identification and quantification of Hypocretin-1\/Orexin-A 1-14 and 1-16 fragments in immunopurified cerebrospinal fluid using LC-MS: Comparison with radioimmunoassay (RIA) determinations"],"prefix":"10.1016","volume":"145","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3006-6265","authenticated-orcid":false,"given":"Anthony","family":"Maus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Figdore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandip","family":"Chavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad","family":"Ruoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lois","family":"Krahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akhilesh","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9297-3271","authenticated-orcid":false,"given":"Joshua","family":"Bornhorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.sleep.2026.109006_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2025.1590556","article-title":"The role of orexin and MCH neurons in the hypothalamus in sleep-wake regulation and learning-forgetting balance","volume":"19","author":"Li","year":"2025","journal-title":"Front Neurosci"},{"issue":"1","key":"10.1016\/j.sleep.2026.109006_bib2","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.yfrne.2007.08.001","article-title":"Orexin neuronal circuitry: role in the regulation of sleep and wakefulness","volume":"29","author":"Ohno","year":"2008","journal-title":"Front Neuroendocrinol"},{"issue":"27","key":"10.1016\/j.sleep.2026.109006_bib3","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1056\/NEJMra1500587","article-title":"Narcolepsy","volume":"373","author":"Scammell","year":"2015","journal-title":"N Engl J Med"},{"issue":"10357","key":"10.1016\/j.sleep.2026.109006_bib4","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(22)01018-2","article-title":"Understanding and approaching excessive daytime sleepiness","volume":"400","author":"P\u00e9rez-Carbonell","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.sleep.2026.109006_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.smrv.2024.101993","article-title":"Recent insights into the pathophysiology of narcolepsy type 1","volume":"78","author":"Vringer","year":"2024","journal-title":"Sleep Med Rev"},{"issue":"5","key":"10.1016\/j.sleep.2026.109006_bib6","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1378\/chest.14-0970","article-title":"International classification of sleep disorders-third edition","volume":"146","author":"Sateia","year":"2014","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.sleep.2026.109006_bib7","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1001\/archneur.59.10.1553","article-title":"The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias","volume":"59","author":"Mignot","year":"2002","journal-title":"Arch Neurol"},{"key":"10.1016\/j.sleep.2026.109006_bib8","first-page":"2313","volume":"vol. 281","year":"2014"},{"key":"10.1016\/j.sleep.2026.109006_bib9","doi-asserted-by":"crossref","unstructured":"Ruoff C, Pizza F, Trotti LM, et al. The MSLT is repeatable in narcolepsy type 1 but not narcolepsy type 2: a retrospective patient study. J Clin Sleep Med. 14(1):65-74. doi:10.5664\/jcsm.6882.","DOI":"10.5664\/jcsm.6882"},{"issue":"4","key":"10.1016\/j.sleep.2026.109006_bib10","doi-asserted-by":"crossref","DOI":"10.1111\/jsr.13631","article-title":"Narcolepsy","volume":"31","author":"Barateau","year":"2022","journal-title":"J Sleep Res"},{"issue":"7","key":"10.1016\/j.sleep.2026.109006_bib11","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S1474-4422(08)70140-6","article-title":"CSF hypocretin-1 assessment in sleep and neurological disorders","volume":"7","author":"Bourgin","year":"2008","journal-title":"Lancet Neurol"},{"issue":"10","key":"10.1016\/j.sleep.2026.109006_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.70984","article-title":"Orexin deficiency in narcolepsy: molecular mechanisms, clinical phenotypes, and emerging therapeutic frontiers","volume":"15","author":"Rauf","year":"2025","journal-title":"Brain Behav"},{"issue":"10357","key":"10.1016\/j.sleep.2026.109006_bib13","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(22)01018-2","article-title":"Understanding and approaching excessive daytime sleepiness","volume":"400","author":"P\u00e9rez-Carbonell","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.sleep.2026.109006_bib14","doi-asserted-by":"crossref","unstructured":"Trotti LM, Staab BA, Rye DB. Test-retest reliability of the multiple sleep latency test in narcolepsy without cataplexy and idiopathic hypersomnia. J Clin Sleep Med. 9(8):789-795. doi:10.5664\/jcsm.2922.","DOI":"10.5664\/jcsm.2922"},{"key":"10.1016\/j.sleep.2026.109006_bib15","doi-asserted-by":"crossref","unstructured":"Trotti LM. Another strike against sleepability. J Clin Sleep Med. 12(4):467-468. doi:10.5664\/jcsm.5666.","DOI":"10.5664\/jcsm.5666"},{"issue":"8","key":"10.1016\/j.sleep.2026.109006_bib16","first-page":"620","article-title":"Value of the multiple sleep latency test (MSLT) for the diagnosis of narcolepsy","volume":"20","author":"Aldrich","year":"1997","journal-title":"Sleep"},{"issue":"12","key":"10.1016\/j.sleep.2026.109006_bib17","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsx164","article-title":"Test\u2013retest reliability of the multiple sleep latency test in central disorders of hypersomnolence","volume":"40","author":"Lopez","year":"2017","journal-title":"Sleep"},{"issue":"12","key":"10.1016\/j.sleep.2026.109006_bib18","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.5664\/jcsm.9620","article-title":"Recommended protocols for the multiple sleep latency test and maintenance of wakefulness test in adults: guidance from the American academy of sleep medicine","volume":"17","author":"Krahn","year":"2021","journal-title":"J Clin Sleep Med"},{"issue":"5","key":"10.1016\/j.sleep.2026.109006_bib19","doi-asserted-by":"crossref","first-page":"zsac052","DOI":"10.1093\/sleep\/zsac052","article-title":"Intermediate hypocretin-1 cerebrospinal fluid levels and typical cataplexy: their significance in the diagnosis of narcolepsy type 1","volume":"45","author":"van der Hoeven","year":"2022","journal-title":"Sleep"},{"issue":"12","key":"10.1016\/j.sleep.2026.109006_bib20","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1136\/jnnp.74.12.1667","article-title":"CSF hypocretin-1 levels in narcolepsy, kleine-levin syndrome, and other hypersomnias and neurological conditions","volume":"74","author":"Dauvilliers","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7","key":"10.1016\/j.sleep.2026.109006_bib21","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.5664\/jcsm.10576","article-title":"Progressive narcolepsy: how to deal with intermediate hypocretin-1 values?","volume":"19","author":"Ricordeau","year":"2023","journal-title":"J Clin Sleep Med"},{"issue":"12","key":"10.1016\/j.sleep.2026.109006_bib22","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1001\/jamaneurol.2014.2510","article-title":"Orexinergic system dysregulation, sleep impairment, and cognitive decline in alzheimer disease","volume":"71","author":"Liguori","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.sleep.2026.109006_bib23","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.sleep.2021.07.007","article-title":"Cerebrospinal fluid orexin in Alzheimer's disease: a systematic review and meta-analysis","volume":"85","author":"Treu","year":"2021","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2026.109006_bib24","doi-asserted-by":"crossref","unstructured":"Lu R, Shah K, Toedebusch CD, et al. Associations of cerebrospinal fluid Orexin-A, alzheimer disease biomarkers, and cognitive performance. Ann Clin Transl Neurol. n\/a(n\/a). doi:10.1002\/acn3.70009.","DOI":"10.1002\/acn3.70009"},{"issue":"1","key":"10.1016\/j.sleep.2026.109006_bib25","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3233\/JAD-190958","article-title":"Positive association between cognitive function and cerebrospinal fluid orexin A levels in alzheimer's disease","volume":"73","author":"Shimizu","year":"2020","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"10.1016\/j.sleep.2026.109006_bib26","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jad.2006.10.019","article-title":"Orexin and psychiatric symptoms in suicide attempters","volume":"100","author":"Brundin","year":"2007","journal-title":"J Affect Disord"},{"issue":"9","key":"10.1016\/j.sleep.2026.109006_bib27","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.euroneuro.2007.01.005","article-title":"Reduced orexin levels in the cerebrospinal fluid of suicidal patients with major depressive disorder","volume":"17","author":"Brundin","year":"2007","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.sleep.2026.109006_bib28","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.yfrne.2018.06.003","article-title":"Orexins and stress","volume":"51","author":"Grafe","year":"2018","journal-title":"Front Neuroendocrinol"},{"key":"10.1016\/j.sleep.2026.109006_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.sleep.2025.106505","article-title":"Detection of reduced orexin-A\/hypocretin-1 and its fragments by orexin-A \u201cgold-standard\u201d radioimmunoassay","volume":"131","author":"Kukkonen","year":"2025","journal-title":"Sleep Med"},{"issue":"24","key":"10.1016\/j.sleep.2026.109006_bib30","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000038539","article-title":"The value of using ELISA to detect orexin-A in cerebrospinal fluid in the diagnosis of narcolepsy","volume":"103","author":"Zhan","year":"2024","journal-title":"Medicine (Baltim)"},{"issue":"11","key":"10.1016\/j.sleep.2026.109006_bib31","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/pcn.12780","article-title":"Measurement of cerebrospinal fluid orexin\u2010a (Hypocretin\u20101) by enzyme\u2010linked immunosorbent assay: a comparison with radioimmunoassay","volume":"72","author":"Ono","year":"2018","journal-title":"Psychiatry Clin Neurosci"},{"issue":"1","key":"10.1016\/j.sleep.2026.109006_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/srep25162","article-title":"From radioimmunoassay to mass spectrometry: a new method to quantify orexin-A (hypocretin-1) in cerebrospinal fluid","volume":"6","author":"Hirtz","year":"2016","journal-title":"Sci Rep"},{"issue":"14","key":"10.1016\/j.sleep.2026.109006_bib33","doi-asserted-by":"crossref","first-page":"9323","DOI":"10.1021\/acs.analchem.9b02710","article-title":"Considerably lower levels of Hypocretin-1 in cerebrospinal fluid is revealed by a novel mass spectrometry method compared with standard radioimmunoassay","volume":"91","author":"B\u00e5rdsen","year":"2019","journal-title":"Anal Chem"},{"key":"10.1016\/j.sleep.2026.109006_bib34","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.clinbiochem.2021.01.009","article-title":"Orexin-A measurement in narcolepsy: a stability study and a comparison of LC-MS\/MS and immunoassays","volume":"90","author":"Lindstr\u00f6m","year":"2021","journal-title":"Clin Biochem"},{"issue":"12","key":"10.1016\/j.sleep.2026.109006_bib35","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsaf237","article-title":"16-mer hypocretin-1\/orexin-A in cerebrospinal fluid to diagnose narcolepsy","volume":"48","author":"Vialaret","year":"2025","journal-title":"Sleep"},{"issue":"2","key":"10.1016\/j.sleep.2026.109006_bib36","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0006-3223(02)01740-7","article-title":"Diurnal variation of cerebrospinal fluid hypocretin-1 (Orexin-A) levels in control and depressed subjects","volume":"54","author":"Salomon","year":"2003","journal-title":"Biol Psychiatry"},{"issue":"3","key":"10.1016\/j.sleep.2026.109006_bib37","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/sleep\/29.3.295","article-title":"Diurnal variation in CSF Orexin-A in healthy Male subjects","volume":"29","author":"Grady","year":"2006","journal-title":"Sleep"},{"issue":"7_Supplement_1","key":"10.1016\/j.sleep.2026.109006_bib38","doi-asserted-by":"crossref","first-page":"4815","DOI":"10.1212\/WNL.0000000000211942","article-title":"Quantitation of hypocretin neuropeptides (Orexin-A and -B) in human cerebrospinal fluid via HPLC with MS\/MS detection (P1-4.002)","volume":"104","author":"Pierce","year":"2025","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.sleep.2026.109006_bib39","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1212\/WNL.57.12.2253","article-title":"CSF hypocretin\/orexin levels in narcolepsy and other neurological conditions","volume":"57","author":"Ripley","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.sleep.2026.109006_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103465","article-title":"A mass spectrometry-based targeted assay for detection of SARS-CoV-2 antigen from clinical specimens","volume":"69","author":"Renuse","year":"2021","journal-title":"EBioMedicine"},{"issue":"4","key":"10.1016\/j.sleep.2026.109006_bib41","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1021\/acs.jproteome.2c00829","article-title":"Identification, measurement, and assessment of the clinical utility of human pancreatic polypeptide by liquid chromatography\u2013tandem mass spectrometry","volume":"22","author":"Maus","year":"2023","journal-title":"J Proteome Res"},{"issue":"1","key":"10.1016\/j.sleep.2026.109006_bib42","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12014-022-09379-5","article-title":"Comparison of intact protein and digested peptide techniques for high throughput proteotyping of ApoE","volume":"19","author":"Maus","year":"2022","journal-title":"Clin Proteomics"},{"issue":"11","key":"10.1016\/j.sleep.2026.109006_bib43","first-page":"783","article-title":"A general regression procedure for method transformation. Application of linear regression procedures for method comparison studies in clinical chemistry, part III","volume":"26","author":"Bablok","year":"1988","journal-title":"J Clin Chem Clin Biochem Z Klin Chem Klin Biochem"},{"issue":"1","key":"10.1016\/j.sleep.2026.109006_bib44","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1021\/pr070501k","article-title":"Integrated analysis of the cerebrospinal fluid peptidome and proteome","volume":"7","author":"Zougman","year":"2008","journal-title":"J Proteome Res"},{"issue":"1","key":"10.1016\/j.sleep.2026.109006_bib45","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41598-018-36942-8","article-title":"HPLC analysis of CSF hypocretin-1 in type 1 and 2 narcolepsy","volume":"9","author":"Sakai","year":"2019","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.sleep.2026.109006_bib46","article-title":"Orexin 1-16 as the stable metabolite behind low CSF orexin\/hypocretin immunoreactivity in narcolepsy","volume":"48","author":"Mignot","year":"2025","journal-title":"SLEEPJ"},{"issue":"12","key":"10.1016\/j.sleep.2026.109006_bib47","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1021\/acs.jpcb.8b10220","article-title":"Determinants of orexin receptor binding and activation\u2014A molecular dynamics study","volume":"123","author":"Karhu","year":"2019","journal-title":"J Phys Chem B"},{"issue":"5","key":"10.1016\/j.sleep.2026.109006_bib48","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0960-894X(01)00043-9","article-title":"Structure\u2013activity analysis of truncated orexin-A analogues at the orexin-1 receptor","volume":"11","author":"Darker","year":"2001","journal-title":"Bioorg Med Chem Lett"},{"issue":"12","key":"10.1016\/j.sleep.2026.109006_bib49","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1021\/ml400333a","article-title":"Truncated orexin peptides: structure\u2013activity relationship studies","volume":"4","author":"German","year":"2013","journal-title":"ACS Med Chem Lett"}],"container-title":["Sleep Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945726002455?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945726002455?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T02:55:45Z","timestamp":1783047345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1389945726002455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":49,"alternative-id":["S1389945726002455"],"URL":"https:\/\/doi.org\/10.1016\/j.sleep.2026.109006","relation":{},"ISSN":["1389-9457"],"issn-type":[{"value":"1389-9457","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification and quantification of Hypocretin-1\/Orexin-A 1-14 and 1-16 fragments in immunopurified cerebrospinal fluid using LC-MS: Comparison with radioimmunoassay (RIA) determinations","name":"articletitle","label":"Article Title"},{"value":"Sleep Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sleep.2026.109006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109006"}}